MR

Mohan Reddy Yanala

Active Director Additional Director DIN 07472061
DIN 07472061 First appointment Apr 2016 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohan Reddy Yanala

Data last updated:

Mohan Reddy Yanala is an Additional Director at Thyropath Labs Private Limited (since 2016). The company operates in Healthcare.

DIN 07472061
Primary Designation Additional Director
Industry Healthcare
First Appointment 11 Apr 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Thyropath Labs Private Limited U85191TG2015PTC102029
Additional Director11 Apr 20162015Active

Board colleagues of Mohan Reddy Yanala

Directorship timeline

Open interactive timeline →
Thyropath Labs Private Limited
Premium access

Shareholding and investment profile for Mohan Reddy Yanala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohan Reddy Yanala

Mohan Reddy Yanala currently holds 1 directorship: Thyropath Labs Private Limited (Additional Director, since 11 Apr 2016).

Mohan Reddy Yanala was first appointed on 11 Apr 2016 as Additional Director at Thyropath Labs Private Limited.

The current boards of Mohan Reddy Yanala's companies include Bixapathy Yadav Mudda (Thyropath Labs Private Limited), Gowri Sree Kadimi (Thyropath Labs Private Limited), Rasheed Shaik (Thyropath Labs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available